The UK Nuclear Medicine Software Market was valued at $39.3 Million in 2025 and projected to reach to $62.8 Million by 2030, representing a compound annual growth rate of 9.9%. The UK nuclear medicine software market is positioned for sustained expansion through 2030, driven by modernisation initiatives within the NHS and increased capital allocation towards diagnostic imaging infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK nuclear medicine software market is valued at £39.3 million in 2025, with a strong projected growth to £62.8 million by 2030, representing a robust 9.9% CAGR specific to the UK market.
Growing investment in nuclear medicine infrastructure across the UK's National Health Service is driving adoption of advanced diagnostic imaging software solutions in hospitals and diagnostic centres nationwide.
UK healthcare facilities are increasingly demanding integrated nuclear medicine software that seamlessly connects with existing PACS and EHR systems, improving workflow efficiency and patient outcomes.
Rising adoption of PET-CT and SPECT imaging technologies across UK medical centres is accelerating the need for sophisticated software platforms to manage, analyse, and report on nuclear medicine studies.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CLOUD-NATIVE PLATFORMS (Integration Complexity) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 9% from 2025 to 2030 |
| Largest Segment | HEALTHCARE PROVIDERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.97 (2025) |
| Revenue Forecast (Billions) | ~USD 1.49 (2030) |
| Segments Covered | Software Type, Workflow, Integration Complexity, Software Licensing, Revenue Model, Application, Type, Therapeutic Area, Technology Maturity, End User |
10 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HEALTHCARE PROVIDERS | 19 | 21 | 23.2 | 25.6 | 28.2 | 31 | 34.1 | 37.5 | 10.1 |
| MEDTECH COMPANIES | 4.4 | 4.9 | 5.4 | 5.9 | 6.5 | 7.1 | 7.8 | 8.5 | 9.5 |
| OTHER END USERS | 2.3 | 2.5 | 2.6 | 2.8 | 3 | 3.1 | 3.3 | 3.5 | 5.9 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 6.5 | 7.3 | 8.1 | 8.9 | 9.9 | 10.9 | 12.1 | 13.4 | 10.6 |
| TOTAL | 32.3 | 35.6 | 39.3 | 43.2 | 47.5 | 52.2 | 57.3 | 62.8 | 9.9 |
The UK nuclear medicine software market is valued at £39.3 million in 2025 and is projected to grow to £62.8 million by 2030.
The UK nuclear medicine software market is expected to grow at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2030.
Key drivers include NHS digital transformation initiatives, increased adoption of AI-enabled diagnostic tools, growing demand for integrated imaging solutions, and modernization of healthcare infrastructure across the UK.
The UK market is led by hospital-based imaging departments, NHS trusts, and private diagnostic centers investing in advanced software platforms for image analysis, patient management, and workflow optimization.
The UK nuclear medicine software market, with a 9.9% CAGR, represents one of Europe's fastest-growing segments, driven by strong healthcare spending, regulatory support, and early adoption of digital health technologies.
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine software market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine software market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine software market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.
Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.
After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine software offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.
In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
Breakdown of Primary Interviews
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue, as of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by software type, workflow, integration complexity, software licensing model, revenue model, application, therapeutic area, technology maturity, end user, and region).

After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine software market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine software market.
Nuclear medicine software refers to specialized platforms and solutions used for visualizing, analyzing, interpreting, and processing medical images and data obtained from nuclear medicine procedures. These solutions are vital for healthcare professionals who are analyzing images from PET and SPECT scans. These software solutions aid in various tasks such as image acquisition, reconstruction, analysis, quantification, dosimetry, treatment planning, radiopharmaceutical management, data management, analytics, and reporting.
Full forecast, segment splits, and company analysis for all Nuclear Medicine Software Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report